What is the share price of Roselabs Finance Ltd (ROSELABS) today?
The share price of ROSELABS as on 23rd October 2026 is ₹20.80. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Roselabs Finance Ltd (ROSELABS) share?
The past returns of Roselabs Finance Ltd (ROSELABS) share are- Past 1 week: 4.52%
- Past 1 month: -8.97%
- Past 3 months: -8.37%
- Past 6 months: -3.44%
- Past 1 year: -36.45%
- Past 3 years: -2.26%
- Past 5 years: -24.23%
What are the peers or stocks similar to Roselabs Finance Ltd (ROSELABS)?
The peers or stocks similar to Roselabs Finance Ltd (ROSELABS) include:What is the market cap of Roselabs Finance Ltd (ROSELABS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Roselabs Finance Ltd (ROSELABS) is ₹19.90 Cr as of 23rd October 2026.What is the 52 week high and low of Roselabs Finance Ltd (ROSELABS) share?
The 52-week high of Roselabs Finance Ltd (ROSELABS) is ₹34.36 and the 52-week low is ₹16.77.What is the PE and PB ratio of Roselabs Finance Ltd (ROSELABS) stock?
The P/E (price-to-earnings) ratio of Roselabs Finance Ltd (ROSELABS) is -66.33. The P/B (price-to-book) ratio is -3.96.Which sector does Roselabs Finance Ltd (ROSELABS) belong to?
Roselabs Finance Ltd (ROSELABS) belongs to the Financials sector & Diversified Financials sub-sector.How to buy Roselabs Finance Ltd (ROSELABS) shares?
You can directly buy Roselabs Finance Ltd (ROSELABS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Roselabs Finance Ltd
ROSELABS Share Price
BSE₹20.800.00% (+0.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max
SIP
ROSELABS Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
ROSELABS Performance & Key Metrics
ROSELABS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -66.33 | -3.96 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 16.38 | 2.12 | 1.24% |
ROSELABS Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
ROSELABS Company Profile
Roselabs Finance is a NBFC whose activities include non-banking financial services, including lending activities and equity/currency derivatives trading
ABCAPITAL
PE Ratio
26.88
26.88
1Y Return
12.74%
12.74%
Buy Reco %
100.00
100.00
MOTILALOFS
PE Ratio
34.11
34.11
1Y Return
9.25%
9.25%
Buy Reco %
100.00
100.00
PE Ratio
30.24
30.24
1Y Return
15.24%
15.24%
Buy Reco %
87.50
87.50
CHOLAHLDNG
PE Ratio
10.46
10.46
1Y Return
32.52%
32.52%
Buy Reco %
100.00
100.00
PE Ratio
36.54
36.54
1Y Return
16.09%
16.09%
Buy Reco %
94.74
94.74
ROSELABS Forecast
ROSELABS Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
ROSELABS
ROSELABS
Income
Balance Sheet
Cash Flow
Quarterly Normal View
ROSELABS Income Statement
ROSELABS Income Statement
Quarterly Normal View
| Quarter | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | sep 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.01 | 0.00 | 0.71 | 0.00 | 0.00 | 1.21 | 0.00 | 0.00 | 0.00 | ||||||||||
Operating & Other expenses | 0.04 | 0.11 | 0.11 | 0.75 | 0.05 | 0.06 | 1.24 | 0.05 | 0.05 | 0.06 | ||||||||||
EBITDA | -0.04 | -0.10 | -0.11 | -0.04 | -0.05 | -0.06 | -0.03 | -0.05 | -0.05 | -0.06 | ||||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBIT | -0.04 | -0.10 | -0.11 | -0.04 | -0.05 | -0.06 | -0.03 | -0.05 | -0.05 | -0.06 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBT | -0.04 | -0.10 | -0.11 | -0.04 | -0.05 | -0.06 | -0.03 | -0.05 | -0.05 | -0.06 | ||||||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 | ||||||||||
| Net Income | -0.04 | -0.10 | -0.11 | -0.04 | -0.05 | -0.06 | -0.03 | -0.16 | -0.05 | -0.06 | ||||||||||
| EPS | -0.04 | -0.09 | -0.11 | -0.05 | -0.05 | -0.06 | -0.04 | -0.16 | -0.05 | -0.06 |
ROSELABS Company Updates
ROSELABS Stock Peers
ROSELABS Past Performance & Peer Comparison
ROSELABS Past Performance & Peer Comparison
Comparing 3 stocks from
FinancialsDiversified Financials
Compare valuation on Screener
FinancialsDiversified Financials
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Roselabs Finance Ltd | -66.33 | -3.96 | — |
| Aditya Birla Capital Ltd | 26.88 | 2.83 | — |
| Motilal Oswal Financial Services Limited | 34.11 | 4.92 | 0.57% |
| Nuvama Wealth Management Ltd | 30.24 | 7.63 | 1.61% |
Compare valuation on ScreenerROSELABS Stock Price Comparison
Compare ROSELABS with any stock or ETFCompare ROSELABS with any stock or ETF
ROSELABS
ROSELABS Holdings
ROSELABS Shareholdings
ROSELABS Promoter Holdings Trend
ROSELABS Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
ROSELABS Institutional Holdings Trend
ROSELABS Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
ROSELABS Shareholding Pattern
ROSELABS Shareholding Pattern
ROSELABS Shareholding History
ROSELABS Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing ROSELABS stock
smallcases containing ROSELABS stock
Looks like this stock is not in any smallcase yet.
ROSELABS Events
ROSELABS Events
ROSELABS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ROSELABS has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
ROSELABS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ROSELABS has not given any dividends in last 5 years
ROSELABS Dividends
ROSELABS Dividends
Hmm, looks like data is unavailable here. Please come back after some timeROSELABS Stock News & Opinions
ROSELABS Stock News & Opinions
Articles & Videos
Corporate
Corporate
Roselabs Finance to review quarterly results at board meeting on October 22, 2026Roselabs Finance Limited will hold a board meeting on Thursday, October 22, 2026, to consider and approve the unaudited financial results along with a limited review report for the quarter and half year ended September 30, 2026, according to a regulatory filing with the BSE Limited. The trading window for designated persons has been closed from October 1, 2026, and will remain so for 48 hours after the financial results are declared.
1 week agoCapital Market - Live
Corporate
Corporate
Roselabs Finance Limited to halt securities trading after September 30, 2026Roselabs Finance Limited will close its trading window for its listed securities from October 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter and half year ended September 30, 2026, as per the company’s code of conduct, Roselabs Finance Limited said in a filing to the BSE Limited on September 28, 2026.
3 weeks agoCapital Market - Live
Corporate
Corporate
Roselabs Finance to hold AGMRoselabs Finance announced that the Annual General Meeting(AGM) of the company will be held on 27 August 2026.
3 months agoCapital Market - Live
Earnings
Earnings
Roselabs Finance reports standalone net loss of Rs 0.05 crore in the June 2026 quarterNet Loss of Roselabs Finance reported to Rs 0.05 crore in the quarter ended June 2026 as against net loss of Rs 0.05 crore during the previous quarter ended June 2025. There were no Sales reported in the quarter ended June 2026 and during the previous quarter ended June 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Corporate
Roselabs Finance to table resultsRoselabs Finance will hold a meeting of the Board of Directors of the Company on 17 July 2026.
3 months agoCapital Market - Live
Earnings
Earnings
Roselabs Finance reports standalone net loss of Rs 0.16 crore in the March 2026 quarterNet Loss of Roselabs Finance reported to Rs 0.16 crore in the quarter ended March 2026 as against net loss of Rs 0.05 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 as against Rs 0.71 crore during the previous quarter ended March 2025. For the full year,net loss reported to Rs 0.31 crore in the year ended March 2026 as against net loss of Rs 0.29 crore during the previous year ended March 2025. Sales rose 70.42% to Rs 1.21 crore in the year ended March 2026 as against Rs 0.71 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales00.71 -100 1.210.71 70 OPM %0-7.04 --16.53-43.66 - PBDT-0.05-0.05 0 -0.20-0.29 31 PBT-0.05-0.05 0 -0.20-0.29 31 NP-0.16-0.05 -220 -0.31-0.29 -7 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Corporate
Roselabs Finance to convene board meetingRoselabs Finance will hold a meeting of the Board of Directors of the Company on 16 April 2026.
6 months agoCapital Market - Live
Earnings
Earnings
Roselabs Finance reports standalone net loss of Rs 0.04 crore in the December 2025 quarterNet Loss of Roselabs Finance reported to Rs 0.04 crore in the quarter ended December 2025 as against net loss of Rs 0.11 crore during the previous quarter ended December 2024. Sales reported to Rs 1.21 crore in the quarter ended December 2025. There were no Sales reported during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales1.210 0 OPM %-3.310 - PBDT-0.04-0.11 64 PBT-0.04-0.11 64 NP-0.04-0.11 64 Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Corporate
Roselabs Finance to convene board meetingRoselabs Finance will hold a meeting of the Board of Directors of the Company on 20 January 2026.Powered by Capital Market - Live
9 months agoCapital Market - Live
Earnings
Earnings
Roselabs Finance reports standalone net loss of Rs 0.06 crore in the September 2025 quarterNet Loss of Roselabs Finance reported to Rs 0.06 crore in the quarter ended September 2025 as against net loss of Rs 0.09 crore during the previous quarter ended September 2024. There were no Sales reported in the quarter ended September 2025 and during the previous quarter ended September 2024.Powered by Capital Market - Live
1 year agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 49.88%, vs industry avg of 15.03%
Over the last 5 years, market share stayed at 0%